nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A8—urine—bipolar disorder	0.0465	0.241	CbGeAlD
Famotidine—CYP2C19—urine—bipolar disorder	0.039	0.202	CbGeAlD
Famotidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.0338	0.0419	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD5—bipolar disorder	0.0268	0.0332	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—bipolar disorder	0.0236	0.0293	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0225	0.0279	CbGpPWpGaD
Famotidine—CYP2C19—blood plasma—bipolar disorder	0.0204	0.106	CbGeAlD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—bipolar disorder	0.0201	0.0249	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—bipolar disorder	0.0199	0.0247	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.0195	0.0241	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.0172	0.0213	CbGpPWpGaD
Famotidine—SLC47A1—adrenal cortex—bipolar disorder	0.0161	0.0833	CbGeAlD
Famotidine—HRH2—Monoamine GPCRs—HTR1A—bipolar disorder	0.0156	0.0194	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD1—bipolar disorder	0.0151	0.0187	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—HTR2C—bipolar disorder	0.0151	0.0187	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD3—bipolar disorder	0.0146	0.0181	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD4—bipolar disorder	0.0142	0.0176	CbGpPWpGaD
Famotidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.0138	0.0172	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD2—bipolar disorder	0.0132	0.0164	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0131	0.0163	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.013	0.0161	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0127	0.0157	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0127	0.0157	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0123	0.0152	CbGpPWpGaD
Famotidine—HRH2—nervous system—bipolar disorder	0.0122	0.0632	CbGeAlD
Famotidine—HRH2—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0119	0.0148	CbGpPWpGaD
Famotidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—bipolar disorder	0.0118	0.0146	CbGpPWpGaD
Famotidine—SLC47A1—thyroid gland—bipolar disorder	0.0112	0.058	CbGeAlD
Famotidine—HRH2—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0111	0.0138	CbGpPWpGaD
Famotidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—bipolar disorder	0.0104	0.0129	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.00978	0.0121	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—GAD1—bipolar disorder	0.00946	0.0117	CbGpPWpGaD
Famotidine—SLC47A1—nervous system—bipolar disorder	0.00942	0.0488	CbGeAlD
Famotidine—HRH2—brain—bipolar disorder	0.00932	0.0483	CbGeAlD
Famotidine—HRH2—G alpha (s) signalling events—DRD5—bipolar disorder	0.00929	0.0115	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—HTR2A—bipolar disorder	0.00926	0.0115	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.00918	0.0114	CbGpPWpGaD
Famotidine—SLC47A1—cerebellum—bipolar disorder	0.00886	0.0459	CbGeAlD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.00886	0.011	CbGpPWpGaD
Famotidine—SLC22A2—Amine compound SLC transporters—SLC6A3—bipolar disorder	0.0082	0.0102	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00784	0.00971	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00778	0.00964	CbGpPWpGaD
Famotidine—SLC22A8—nervous system—bipolar disorder	0.00722	0.0374	CbGeAlD
Famotidine—SLC47A1—brain—bipolar disorder	0.0072	0.0373	CbGeAlD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.00703	0.00871	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.00679	0.00842	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—ADM—bipolar disorder	0.00672	0.00833	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—TSHB—bipolar disorder	0.00655	0.00811	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—PDE4B—bipolar disorder	0.00655	0.00811	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.00639	0.00792	CbGpPWpGaD
Famotidine—SLC22A8—brain—bipolar disorder	0.00552	0.0286	CbGeAlD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—MAOA—bipolar disorder	0.00529	0.00655	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—DRD1—bipolar disorder	0.00524	0.00649	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00517	0.00641	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.00493	0.00611	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—ADCY2—bipolar disorder	0.00463	0.00574	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.00461	0.00571	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.0045	0.00558	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.00445	0.00551	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00443	0.00549	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.00417	0.00517	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—MAOA—bipolar disorder	0.00398	0.00493	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CPLX1—bipolar disorder	0.00378	0.00468	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00369	0.00457	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00341	0.00423	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD5—bipolar disorder	0.00337	0.00418	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.00321	0.00397	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00312	0.00387	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00312	0.00387	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00302	0.00374	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00291	0.00361	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00291	0.00361	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.0029	0.0036	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.00283	0.00351	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00282	0.0035	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.00277	0.00343	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00274	0.00339	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.00271	0.00336	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00265	0.00328	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00261	0.00324	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00258	0.0032	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00257	0.00318	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—POMC—bipolar disorder	0.00256	0.00318	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00255	0.00316	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00255	0.00315	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.00252	0.00313	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.0025	0.00309	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.0025	0.00309	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADM—bipolar disorder	0.00244	0.00302	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00242	0.003	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—TSHB—bipolar disorder	0.00238	0.00295	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—TACR1—bipolar disorder	0.00238	0.00295	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00235	0.00291	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00226	0.0028	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00224	0.00278	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00219	0.00271	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIK2—bipolar disorder	0.00217	0.00269	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIN1—bipolar disorder	0.00212	0.00263	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00212	0.00263	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.00209	0.0026	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DGKH—bipolar disorder	0.00208	0.00258	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GAD1—bipolar disorder	0.00208	0.00258	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.00202	0.0025	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR1A—bipolar disorder	0.00197	0.00244	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—TAC1—bipolar disorder	0.00194	0.0024	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CACNB2—bipolar disorder	0.00193	0.0024	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD5—bipolar disorder	0.00191	0.00236	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2C—bipolar disorder	0.0019	0.00235	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD1—bipolar disorder	0.0019	0.00235	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DGKH—bipolar disorder	0.00189	0.00235	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—RGS4—bipolar disorder	0.00187	0.00232	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD3—bipolar disorder	0.00184	0.00228	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00182	0.00226	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.0018	0.00224	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.0018	0.00223	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00179	0.00221	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD4—bipolar disorder	0.00179	0.00221	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00179	0.00221	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD5—bipolar disorder	0.00173	0.00215	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RGS4—bipolar disorder	0.0017	0.0021	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD2—bipolar disorder	0.00166	0.00206	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00161	0.00199	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SNAP25—bipolar disorder	0.00155	0.00191	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00153	0.0019	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00153	0.00189	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00152	0.00188	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—IMPA2—bipolar disorder	0.00148	0.00183	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00148	0.00183	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.00146	0.00181	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00145	0.0018	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—TRPC3—bipolar disorder	0.00145	0.00179	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIN2B—bipolar disorder	0.0014	0.00173	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADM—bipolar disorder	0.00138	0.00171	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A3—bipolar disorder	0.00138	0.00171	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—ADCY2—bipolar disorder	0.00137	0.00169	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—TSHB—bipolar disorder	0.00134	0.00166	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—TACR1—bipolar disorder	0.00134	0.00166	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PDE4B—bipolar disorder	0.00134	0.00166	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TRPC3—bipolar disorder	0.00131	0.00163	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADM—bipolar disorder	0.00125	0.00155	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00122	0.00152	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PDE4B—bipolar disorder	0.00122	0.00151	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TSHB—bipolar disorder	0.00122	0.00151	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TACR1—bipolar disorder	0.00122	0.00151	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKR1C4—bipolar disorder	0.00122	0.00151	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00117	0.00146	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—COMT—bipolar disorder	0.00117	0.00145	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2A—bipolar disorder	0.00117	0.00144	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MAOA—bipolar disorder	0.00116	0.00144	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DGKH—bipolar disorder	0.00112	0.00139	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00112	0.00139	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR1A—bipolar disorder	0.00111	0.00138	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—TAC1—bipolar disorder	0.0011	0.00136	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2C—bipolar disorder	0.00107	0.00133	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD1—bipolar disorder	0.00107	0.00133	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00106	0.00132	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00106	0.00131	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD3—bipolar disorder	0.00104	0.00129	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00103	0.00128	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD5—bipolar disorder	0.00102	0.00127	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR1A—bipolar disorder	0.00101	0.00125	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD4—bipolar disorder	0.00101	0.00125	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RGS4—bipolar disorder	0.001	0.00124	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—IMPA1—bipolar disorder	0.000997	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TAC1—bipolar disorder	0.000995	0.00123	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD1—bipolar disorder	0.000975	0.00121	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2C—bipolar disorder	0.000975	0.00121	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—COMT—bipolar disorder	0.000965	0.0012	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOA—bipolar disorder	0.000959	0.00119	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—COMT—bipolar disorder	0.000952	0.00118	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000951	0.00118	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD3—bipolar disorder	0.000945	0.00117	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD2—bipolar disorder	0.000941	0.00117	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—POMC—bipolar disorder	0.000931	0.00115	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000927	0.00115	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD4—bipolar disorder	0.000917	0.00114	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADCY2—bipolar disorder	0.000863	0.00107	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD2—bipolar disorder	0.000854	0.00106	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NDUFV2—bipolar disorder	0.000848	0.00105	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—IMPA2—bipolar disorder	0.000826	0.00102	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKR1C4—bipolar disorder	0.000821	0.00102	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TRPC3—bipolar disorder	0.000775	0.000961	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000741	0.000918	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADM—bipolar disorder	0.00074	0.000916	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NR1D1—bipolar disorder	0.000737	0.000914	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000735	0.000911	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDE4B—bipolar disorder	0.000721	0.000893	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TSHB—bipolar disorder	0.000721	0.000893	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TACR1—bipolar disorder	0.000721	0.000893	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCAN—bipolar disorder	0.000705	0.000874	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC5A3—bipolar disorder	0.000691	0.000856	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000659	0.000816	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000628	0.000778	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—POMC—bipolar disorder	0.000624	0.000773	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2A—bipolar disorder	0.000598	0.000741	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR1A—bipolar disorder	0.000597	0.000739	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TAC1—bipolar disorder	0.000588	0.000728	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD1—bipolar disorder	0.000576	0.000714	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2C—bipolar disorder	0.000576	0.000714	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK2—bipolar disorder	0.000561	0.000694	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD3—bipolar disorder	0.000558	0.000691	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—IMPA1—bipolar disorder	0.000558	0.000691	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GSK3A—bipolar disorder	0.000556	0.000688	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000545	0.000676	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD4—bipolar disorder	0.000542	0.000671	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—POMC—bipolar disorder	0.000526	0.000652	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADCY2—bipolar disorder	0.00051	0.000632	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TCF7L2—bipolar disorder	0.000508	0.00063	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD2—bipolar disorder	0.000505	0.000625	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CLOCK—bipolar disorder	0.0005	0.000619	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TPH2—bipolar disorder	0.000487	0.000603	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TSHB—bipolar disorder	0.000487	0.000603	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNB2—bipolar disorder	0.000487	0.000603	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DPYD—bipolar disorder	0.000479	0.000593	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—POMC—bipolar disorder	0.000478	0.000592	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NDUFV2—bipolar disorder	0.000474	0.000588	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKR1C4—bipolar disorder	0.000459	0.000569	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK1—bipolar disorder	0.000457	0.000566	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CACNA1C—bipolar disorder	0.000445	0.000552	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—S100B—bipolar disorder	0.000444	0.00055	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3C2A—bipolar disorder	0.000434	0.000538	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NR1D1—bipolar disorder	0.000413	0.000511	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCAN—bipolar disorder	0.000395	0.000489	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NRG1—bipolar disorder	0.000392	0.000486	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SNAP25—bipolar disorder	0.000389	0.000482	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC5A3—bipolar disorder	0.000387	0.000479	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—bipolar disorder	0.000353	0.000438	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADCY2—bipolar disorder	0.000344	0.000427	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COMT—bipolar disorder	0.000295	0.000365	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOA—bipolar disorder	0.000293	0.000363	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GSK3B—bipolar disorder	0.000285	0.000353	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—POMC—bipolar disorder	0.000282	0.00035	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—bipolar disorder	0.000281	0.000348	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CLOCK—bipolar disorder	0.00028	0.000346	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TPH2—bipolar disorder	0.000272	0.000338	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TSHB—bipolar disorder	0.000272	0.000338	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNB2—bipolar disorder	0.000272	0.000338	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DPYD—bipolar disorder	0.000268	0.000332	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CACNA1C—bipolar disorder	0.000249	0.000309	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	0.000243	0.000301	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.00024	0.000297	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—bipolar disorder	0.000238	0.000295	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SNAP25—bipolar disorder	0.000218	0.00027	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADCY2—bipolar disorder	0.000193	0.000239	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—POMC—bipolar disorder	0.000191	0.000236	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—bipolar disorder	0.00019	0.000235	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COMT—bipolar disorder	0.000165	0.000205	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOA—bipolar disorder	0.000164	0.000203	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—bipolar disorder	0.000133	0.000165	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—POMC—bipolar disorder	0.000107	0.000132	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—bipolar disorder	0.000106	0.000132	CbGpPWpGaD
